Search results for AstraZeneca
AI & Enterprise
Fully AI-designed new drugs are only a matter of time, AstraZeneca blueprint shows
Artificial intelligence is becoming core infrastructure in biopharmaceutical development, rapidly changing how drug candidates are found and validated. AstraZeneca says computing now reinforces the entire process from design and production to verification and analysis, shortening development cycles and boosting productivity. The company uses a build-measure-learn loop, multimodal datasets and precision screening, and is building an AI- and robot-enabled lab in Cambridge, Massachusetts. Executives say de novo, fully AI-generated biologics are an industry goal but require richer data, benchmarks and talent, with human oversight remaining central.
AI & Enterprise
MegazoneCloud shares quantum technology industry strategy with UT Austin MBA students
MegazoneCloud said it shared strategies for industrial use of quantum technology with about 30 University of Texas at Austin McCombs School of Business MBA students. The company hosted 37 visitors on March 10 at its industry-academia-research center in Gwacheon for a Quantum & Cloud Strategy Day event as part of the MBA program’s Global Connections field study. It introduced quantum technology applications across sectors and discussed corporate strategic responses.
Industry
Yeo Han-koo steps up push to resolve trade issues at Davos forum
South Korea\'s top trade negotiator Yeo Han-koo held broad trade diplomacy at the World Economic Forum in Davos, meeting trade ministers and executives about 50 times, the industry ministry said on Jan. 23. He discussed bilateral issues with the United States and held talks on steel import restrictions with the European Union and Canada. He also pushed for faster negotiations on multiple FTAs and attended WTO ministerial meetings focused on restoring the multilateral trading order.